Belite Bio (BLTE) Other Accumulated Expenses (2021 - 2025)

Belite Bio's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $5000.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses fell 98.27% year-over-year to $5000.0; the TTM figure through Dec 2025 stood at $5000.0 (down 98.27% YoY), while the FY2025 annual figure was $5000.0, down 98.27% from the prior year.
• Other Accumulated Expenses was $5000.0 for Q4 2025 at Belite Bio, down from $289000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $289000.0 in Q4 2024 to a low of $5000.0 in Q4 2025.
• Historically, Other Accumulated Expenses has averaged $122400.0 across 5 years, with a median of $95000.0 in 2021.
• The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses surged 101.35% in 2023, then plunged 98.27% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $95000.0 in 2021, then decreased by 22.11% to $74000.0 in 2022, then soared by 101.35% to $149000.0 in 2023, then surged by 93.96% to $289000.0 in 2024, then slumped by 98.27% to $5000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $5000.0 (Q4 2025), $289000.0 (Q4 2024), and $149000.0 (Q4 2023), per Business Quant data.